首页> 美国卫生研究院文献>International Journal of Surgery Protocols >Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with completeear complete clinical and radiological response (Complete Responders in the Breast – CRBr) – Trial design and conduct

【2h】

Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with completeear complete clinical and radiological response (Complete Responders in the Breast – CRBr) – Trial design and conduct

机译：核心活检在预测具有完全/接近完全临床和放射学反应（乳房完全反应者– CRBr）的患者中乳房的病理完全反应中的准确性–试验设计和实施

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 International Journal of Surgery Protocols
作者
N. Hariharan; T.S. Rao; S. Rajappa; C.C.K. Naidu; K.V.V.N. Raju; V. Koppula; S. Murthy; S. Kodandapani;
展开▼
作者单位

展开▼
年(卷),期 2019(16),-1
年度 2019
页码 -1
总页数 4
原文格式 PDF
正文语种
中图分类外科学;
关键词
Pathologic complete response; Core biopsy; Complete responders;

机译：病理完全缓解;核心活检;完全缓解;
入库时间 2022-08-21 11:47:36

相似文献

外文文献
中文文献
专利

1. Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：NRG-BR005的初步分析，II期试验评估肿瘤床活组织检查预测临床/放射性化疗后临床/放射性完全反应（NCT）患者病理完全反应（PCR）进行病理完全反应（NCT），探讨无手术治疗哺乳治疗的可行性
2. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment) [J] . van der Noordaa M. E. M., van Duijnhoven F. H., Loo C. E., The Breast : . 2018,第期

机译：鉴定乳房后乳房的病理完全反应在具有超声引导的活组织检查最终省略手术中的乳房治疗：微米试验的研究和可行性（微创完整响应评估）
3. Total pathological complete response versus breast pathological complete response in clinical trials of reference and biosimilar trastuzumab in the neoadjuvant treatment of breast cancer [J] . Stebbing Justin, Baranau Yauheni, Manikhas Alexey, Expert review of anticancer therapy . 2018,第1a6期

机译：在乳腺癌Neoadjuvant治疗中的临床和生物仿制物曲据临床试验中的总病理完全反应与乳房病理完全反应
4. Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Deep Learning with Integrative Imaging, Molecular and Demographic Data [C] . Hongyi Duanmu, Pauline Boning Huang, Srinidhi Brahmavar, International Conference on Medical Image Computing and Computer-Assisted Intervention . 2020

机译：利用综合成像，分子和人口统计数据预测对乳腺癌新辅助化疗的病理完全反应
5. Using Preoperative Mri-guided Biopsies to Predict Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer [D] . Kim, Jiyoon. 2019

机译：在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
6. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) [O] . Simon Peter Gampenrieder, Andreas Peer, Christian Weismann, 2019

机译：早期乳腺癌新辅助化疗后的造影增强磁共振成像（CE-MRI）中的放射学完全缓解（rCR）预测无复发生存但病理完全缓解（pCR）无法预测
7. Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with complete/near complete clinical and radiological response (Complete Responders in the Breast – CRBr) – Trial design and conduct [O] . N. Hariharan, T.S. Rao, S. Rajappa, 2019

机译：核心活组织检查预测乳腺癌患者的病理完全反应的准确性（完整临床和放射响应（乳房CRBR中的完整响应者） - 试验设计和行为

Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with completeear complete clinical and radiological response (Complete Responders in the Breast – CRBr) – Trial design and conduct

著录项

相似文献

相关主题

期刊订阅